Cumberland Pharmaceuticals
CPIX
31 hedge funds and large institutions have $9.77M invested in Cumberland Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
11% more funds holding
Funds holding: 28 → 31 (+3)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
4.18% less ownership
Funds ownership: 25.81% → 21.62% (-4.2%)
14% less capital invested
Capital invested by funds: $11.4M → $9.77M (-$1.65M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$253K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$228K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$55.3K |
| 4 |
MHS
M Holdings Securities
Portland,
Oregon
|
+$34.9K |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$34.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
-$1.98M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$557K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$143K |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
-$13.7K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$12.5K |
CPIX Hedge Fund Activity: Q1 2021 in Review
31 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q1 2021, worth a combined $9.77M — down 14% from $11.4M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CPIX positions and 2 closed out — a net gain of 3 holders — while 7 added to existing stakes and 7 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $253K. The largest seller was Ariel Investments, cutting an estimated $1.98M.
- 31 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q1 2021, up from 28 in Q4 2020.
- Funds reported $9.77M of Cumberland Pharmaceuticals stock for Q1 2021, down 14% quarter-over-quarter.
- 5 funds opened new Cumberland Pharmaceuticals positions in Q1 2021 and 2 closed out, a net change of +3 holders.
- The largest Cumberland Pharmaceuticals buyer in Q1 2021 was Renaissance Technologies, an estimated $253K added.
- The largest Cumberland Pharmaceuticals seller in Q1 2021 was Ariel Investments, an estimated $1.98M sold.
Based on aggregated 13F filings for Q1 2021.